Remove Bioinformatics Remove Genetics Remove Genome Remove Pharma Companies
article thumbnail

Open science, genomics, and the quiet revolution in our approach to pharma

Drug Discovery World

Evan Floden , CEO of Seqera Labs examines how data sharing platforms are impacting cancer and genomics research. Increasingly, major collaborative life sciences projects, like the Human Genome Project or Human Cell Atlas, are driving advancements and organisations – both public and private – are taking note.

Genome 52
article thumbnail

Big pharma companies partner to form AI-based start-up

pharmaphorum

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. At times, companies invest millions of dollars in developing and studying a therapy that may find to be ineffective. The partnership.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sandoz, Ares extend digital alliance on antimicrobial resistance

pharmaphorum

Novartis’ generics unit Sandoz has moved on to the next stage of a collaboration with Ares Genetics, which is focusing on the use of artificial intelligence to track antimicrobial resistance (AMR), improve diagnoses and guide the most effective use of antibiotics. “AMR, which is now estimated to directly account for nearly 1.3

article thumbnail

Top 10 Fastest Growing Biotech Companies in 2023

XTalks

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times.

Genetics 111
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

Gene-to-antibody production begins with scientists entering antibody sequences as starting material, after which bioinformatics tools filter out potentially non-viable sequences. Researchers used it to elucidate the genetic code and mechanism of protein synthesis back in the 1960s. This approach has been around for a while.

DNA 98